Navigation Links
Tandem Diabetes Care Names Lonnie Smith As Chairman Of The Board
Date:2/20/2013

SAN DIEGO, Feb. 20, 2013 /PRNewswire/ -- Tandem Diabetes Care, Inc. ("Tandem") today announced the appointment of Lonnie Smith as Chairman of its Board of Directors.  Mr. Smith is Chairman of the Board and former chief executive officer of Intuitive Surgical.  He succeeds Dick Allen , who will continue as a member of the Board.

"Lonnie is an ideal Board leader for the Company at this exciting juncture in our evolution," said Dick Allen . "I am confident that with Lonnie's strategic guidance, the very successful operating experience of our CEO, Kim Blickenstaff , and the talents of our committed employees, we will significantly expand our commercial capabilities to get the t:slim Insulin Pump and our future products in the hands of people in the diabetes community who can benefit from them most."

"I am honored to be named Chairman and am committed to maximizing the opportunities we have at Tandem," said Lonnie Smith .  "The t:slim Insulin Pump is an exciting product, and I believe Tandem's development pipeline includes technology that will change the face of infusion therapy for people with diabetes."

Lonnie Smith 's career in the medical device industry spans more than four decades.  Mr. Smith is Chairman of the Board and an executive officer of Intuitive Surgical, where he previously served as chief executive officer from May 1997 to January 1, 2010.  Prior to joining Intuitive Surgical, Mr. Smith was senior executive vice president for Hillenbrand Industries, and he has also held positions with The Boston Consulting Group and IBM Corporation. Mr. Smith received his MBA from Harvard Business School and a BS in Electrical Engineering from Utah State University.

About Tandem Diabetes Care, Inc.  

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a privately held company dedicated to advancing the management of diabetes through novel technologies. The Company offers a comprehensive, user-centric and integrated approach to product design, development, and customer care. Tandem Diabetes Care is based in San Diego, Calif.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslim.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetesCorp.

t:slim and Tandem Diabetes Care are registered trademarks of Tandem Diabetes Care, Inc.


'/>"/>
SOURCE Tandem Diabetes Care, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tandem Diabetes Care Acquires Select Patents and Patent Applications from Smiths Medical
2. Data Related to Chimerixs Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings
3. Data Demonstrating the Safety and Efficacy of Chimerixs Antiviral CMX001 Presented at BMT Tandem Meetings
4. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
5. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
6. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
7. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
8. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
9. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
10. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
11. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
Breaking Medicine News(10 mins):